Treatment Options, Comparative Effectiveness, and Coordinated Care: A Psoriatic Disease Update for Managed Care and Specialty Pharmacy
Clinical Primer
- Release date: March 10, 2017
- Expiration date: September 30, 2018
- Estimated Time to Complete Activity: 1.0 hour
- Compatible with all modern browsers and mobile devices
| REVIEW BOARD FACULTY |
|
 |
TARGET AUDIENCE
- Medical Directors and Pharmacy Directors from health plans, HMOs, integrated health systems, employers, quality organizations, and other managed care organizations (MCOs)
- Managed care-affiliated care team members involved with patient evaluation, education, and follow-up for psoriatic disease patients including: physicians, pharmacists, registered nurses, and case managers
EDUCATIONAL OBJECTIVES
At the conclusion of this activity, participants should be able to demonstrate improved ability to:
- Assess current and emerging therapies for the treatment of psoriasis and psoriatic arthritis and cite their clinical trial data.
- Review the comparative effectiveness research (CER) framework and discuss application of CER findings to benefit design and clinical decision making for patients with psoriatic disease.
- Identify barriers to adherence and formulate strategies to overcome them.
- Integrate interventions to coordinate health plan and affiliated provider's efforts in the health care reform era that will lead to better outcomes for patients with psoriasis and psoriatic arthritis.
ACCREDITATION
Physician Continuing Medical Education
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Annenberg Center for Health Sciences at Eisenhower and Impact Education, LLC. The Annenberg Center for Health Sciences at Eisenhower is accredited by the ACCME to provide continuing medical education for physicians.
The Annenberg Center for Health Sciences at Eisenhower designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Pharmacy Education
|
 |
The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. |
This enduring activity has been assigned ACPE Universal Activity Number 0797-9999-17-026-H04-P. This program is designated for up to 1.0 contact hour (0.10 CEU) of continuing pharmacy education credit.
Type of Activity
Knowledge
Continuing Nursing Education
Annenberg Center for Health Sciences at Eisenhower is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
1.0 contact hour may be earned for successful completion of this activity.
DISCLOSURE OF CONFLICTS OF INTEREST
The Annenberg Center for Health Sciences at Eisenhower requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to the Annenberg Center for Health Sciences at Eisenhower policy. The Annenberg Center for Health Sciences at Eisenhower is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
| Name of Faculty or Presenter |
Reported Financial Relationship |
| Robin Dore, MD |
Contracted Research: Pfizer, Inc., Amgen, Inc., AbbVie, Inc., and Novartis Pharmaceuticals Corporation
Consulting Fees (eg, Advisory Boards): Amgen, Inc.
Fees for Non-CME/CE Services Received Directly from a Commercial Interest or their Agents (e.g., Speakers’ Bureau): Pfizer, Inc., Amgen, Inc., AbbVie, Inc., Celgene Corporation, and Novartis Pharmaceuticals Corporation
|
| Jeffrey Dunn, PharmD, MBA |
No financial interest/relationships relating to the topic of this activity |
| Alan Menter, MD |
Advisory Board: AbbVie, Inc., Allergan Pharmaceuticals, Amgen, Inc., Boehringer Ingleheim Pharmaceuticals, Inc., Eli-Lilly, Janssen Biotech, Inc., LEO Pharma
Consultant: AbbVie, Inc., Allergan Pharmaceuticals, Amgen Inc., Eli-Lilly, Galderma, Janssen Biotech, Inc., LEO Pharma, Novartis Pharmaceuticals Corporation, Pfizer, Inc.
Investigator: AbbVie, Inc., Amgen, Inc., Boehringer Ingelheim Pharmaceuticals, Inc., Celgene Corporation, Dermira, Eli-Lilly, Janssen Biotech, Inc., LEO Pharma, Merck & Co., Inc., Neothetics, Novartis Pharmaceuticals Corporation, Pfizer, Inc., Regeneron, Syntrix
Speakers’ Bureau: AbbVie, Inc., Amgen, Janssen Biotech, Inc., Leo Pharma
|
| John Knispel, MD, CPE, FACOG |
No financial interest/relationships relating to the topic of this activity |
The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
| Name of Impact Education, LLC Planner or Manager |
Reported Financial Relationship |
| Steven Casebeer, MBA |
No financial interest/relationship relating to the topic of this activity |
| Keith Engelke, PhD |
No financial interest/relationship relating to the topic of this activity |
The following PIM planners and managers, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CHCP, Judi Smelker-Mitchek, MBA, MSN, RN and Jan Schultz, MSN, RN, CHCP have nothing to disclose.
Charles E. Willis, MBA, Director of Continuing Education, Amanda Sewell, MBA, Manager of Continuing Education, and Alma Perez, Accreditation Specialist from the Annenberg Center for Health Sciences at Eisenhower have no relevant commercial relationships to disclose.
|
DISCLOSURE OF UNLABELED USE
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the Food and Drug Administration. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
DISCLAIMER
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
METHOD OF PARTICIPATION AND REQUEST FOR CREDIT
There are no fees for participating and receiving CME/CE credit for this activity. During the period of March 10, 2017, through September 30, 2018, participants must 1) read the learning objectives and faculty disclosures; 2) study the educational activity; 3) successfully complete the post-test with a score of 75% or better; 4) and complete the evaluation form. Upon completion of the full CME/CE activity, a certificate will be made available immediately to download and print.
For Pharmacists: Upon successfully completing the post-test with a score of 75% or better and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 4 weeks.
MEDIA
Internet
FEE INFORMATION
There is no fee for this educational activity.
